Acl Reconstruction denied as non-formulary by Aetna?

Aetna's specific coverage criteria for acl reconstruction are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna May Issue a Non-Formulary Denial for ACL Reconstruction

ACL reconstruction is a surgical procedure, not a drug, so a "non-formulary" denial in this context almost always means that the specific surgeon, facility, implant, or graft material involved is outside Aetna's covered network or approved product list — not that the procedure itself is excluded. The most common scenarios are: the surgeon or facility is out-of-network and a network alternative is being required; a specific implant, synthetic graft, or biological product used during the procedure is not on Aetna's approved device or supply list; or the service was routed through a facility tier that requires additional authorization. Understanding exactly which element triggered the non-formulary flag is the first step.

## Your Right to Appeal

Under ACA §2719, most plans must provide independent external review after internal appeals are exhausted. ERISA §503 governs employer-plan members. External review must typically be requested within four months of the final internal denial. Additionally, the ACA's network adequacy and continuity-of-care provisions may apply if no in-network provider with the appropriate surgical expertise is reasonably available. An expedited appeal is available when delay would seriously jeopardize health.

## Building Your Appeal

1. Identify the specific non-formulary element — request the denial letter's full basis from Aetna. Determine whether the issue is: (a) out-of-network surgeon or facility, (b) a specific implant or graft product not on an approved list, or (c) a facility tier or site-of-service issue. 2. Network adequacy or access exception — if the treating surgeon is out-of-network, document that no in-network surgeon with equivalent subspecialty experience (e.g., sports medicine orthopedics with ACL reconstruction volume) is available within a reasonable distance or time. Aetna's plan documents describe the network adequacy exception process. 3. Implant or product documentation — if the denial targets a specific graft or implant, obtain the manufacturer's documentation showing FDA clearance or approval and any available clinical evidence supporting its use. The surgeon should provide a letter explaining why this specific product was selected for this patient. 4. Prescriber letter addressing network or product issue — the orthopedic surgeon should write a letter addressing the specific non-formulary basis, providing clinical justification and referencing any applicable specialty-society guidance. 5. Continuity of care — if surgery is already scheduled or in progress, invoke Aetna's continuity-of-care policy to request that the treating surgeon be covered at in-network rates for the duration of this episode.

## Criteria-Mapping Structure

Obtain Aetna's published exception or access-to-care criteria. Create a two-column table: left column lists each exception criterion; right column provides the specific clinical or administrative evidence that satisfies it. Attach supporting documentation as numbered exhibits.